Literature DB >> 32111120

Evaluating Partial Series Childhood Vaccination Services in a Mobile Clinic Setting.

Weiwei Chen1, Sanghamitra M Misra2,3, Fangjun Zhou4, Leila C Sahni2,3, Julie A Boom2,3, Mark Messonnier4.   

Abstract

This study aims to evaluate the cost-benefit of vaccination services, mostly partial series administration, provided by a mobile clinic program (MCP) in Houston for children of transient and low-income families. The study included 469 patients who visited the mobile clinics on regular service days in 2 study periods in 2014 and 836 patients who attended vaccination events in the summer of 2014. The benefit of partial series vaccination was estimated based on vaccine efficacy/effectiveness data. Our conservative cost-benefit estimates show that, compared with office-based settings, every dollar spent on vaccination by the MCP would result in $0.9 societal cost averted as an incremental benefit in regular service days and $3.7 during vaccination-only events. To further improve the cost-benefit of vaccination services in the MCP, decision-makers and stakeholders may consider improving work efficiency during regular service days or hosting more vaccination events.

Entities:  

Keywords:  childhood vaccination; cost-benefit analysis; mobile clinic; partial series

Mesh:

Year:  2020        PMID: 32111120      PMCID: PMC8721745          DOI: 10.1177/0009922820908586

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  24 in total

1.  Mobile dental units: leasing or buying? A dollar-cost analysis.

Authors:  Oscar Arevalo; Daniel M Saman; Alice Bonaime; Judy Skelton
Journal:  J Public Health Dent       Date:  2010       Impact factor: 1.821

2.  Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.

Authors:  Guillermo M Ruiz-Palacios; Irene Pérez-Schael; F Raúl Velázquez; Hector Abate; Thomas Breuer; SueAnn Costa Clemens; Brigitte Cheuvart; Felix Espinoza; Paul Gillard; Bruce L Innis; Yolanda Cervantes; Alexandre C Linhares; Pío López; Mercedes Macías-Parra; Eduardo Ortega-Barría; Vesta Richardson; Doris Maribel Rivera-Medina; Luis Rivera; Belén Salinas; Noris Pavía-Ruz; Jorge Salmerón; Ricardo Rüttimann; Juan Carlos Tinoco; Pilar Rubio; Ernesto Nuñez; M Lourdes Guerrero; Juan Pablo Yarzábal; Silvia Damaso; Nadia Tornieporth; Xavier Sáez-Llorens; Rodrigo F Vergara; Timo Vesikari; Alain Bouckenooghe; Ralf Clemens; Béatrice De Vos; Miguel O'Ryan
Journal:  N Engl J Med       Date:  2006-01-05       Impact factor: 91.245

3.  Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.

Authors:  Timo Vesikari; David O Matson; Penelope Dennehy; Pierre Van Damme; Mathuram Santosham; Zoe Rodriguez; Michael J Dallas; Joseph F Heyse; Michelle G Goveia; Steven B Black; Henry R Shinefield; Celia D C Christie; Samuli Ylitalo; Robbin F Itzler; Michele L Coia; Matthew T Onorato; Ben A Adeyi; Gary S Marshall; Leif Gothefors; Dirk Campens; Aino Karvonen; James P Watt; Katherine L O'Brien; Mark J DiNubile; H Fred Clark; John W Boslego; Paul A Offit; Penny M Heaton
Journal:  N Engl J Med       Date:  2006-01-05       Impact factor: 91.245

4.  Mobile clinic in Massachusetts associated with cost savings from lowering blood pressure and emergency department use.

Authors:  Zirui Song; Caterina Hill; Jennifer Bennet; Anthony Vavasis; Nancy E Oriol
Journal:  Health Aff (Millwood)       Date:  2013-01       Impact factor: 6.301

5.  Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.

Authors:  Julie A Boom; Jacqueline E Tate; Leila C Sahni; Marcia A Rench; Jennifer J Hull; Jon R Gentsch; Manish M Patel; Carol J Baker; Umesh D Parashar
Journal:  Pediatrics       Date:  2010-01-18       Impact factor: 7.124

6.  Economic evaluation of the routine childhood immunization program in the United States, 2009.

Authors:  Fangjun Zhou; Abigail Shefer; Jay Wenger; Mark Messonnier; Li Yan Wang; Adriana Lopez; Matthew Moore; Trudy V Murphy; Margaret Cortese; Lance Rodewald
Journal:  Pediatrics       Date:  2014-03-03       Impact factor: 7.124

7.  Mobile health care operations and return on investment in predominantly underserved children with asthma: the breathmobile program.

Authors:  Tricia Morphew; Lyne Scott; Marilyn Li; Stanley P Galant; Webster Wong; Maria I Garcia Lloret; Felita Jones; Mary Elizabeth Bollinger; Craig A Jones
Journal:  Popul Health Manag       Date:  2013-08       Impact factor: 2.459

8.  Cost Effectiveness of Influenza Vaccine for U.S. Children: Live Attenuated and Inactivated Influenza Vaccine.

Authors:  Eunha Shim; Shawn T Brown; Jay DePasse; Mary Patricia Nowalk; Jonathan M Raviotta; Kenneth J Smith; Richard K Zimmerman
Journal:  Am J Prev Med       Date:  2016-04-11       Impact factor: 5.043

9.  Effectiveness of pentavalent rotavirus vaccine against severe disease.

Authors:  Mary Allen Staat; Daniel C Payne; Stephanie Donauer; Geoffrey A Weinberg; Kathryn M Edwards; Peter G Szilagyi; Marie R Griffin; Caroline B Hall; Aaron T Curns; Jon R Gentsch; Shelia Salisbury; Gerry Fairbrother; Umesh D Parashar
Journal:  Pediatrics       Date:  2011-07-18       Impact factor: 7.124

10.  Use of a community mobile health van to increase early access to prenatal care.

Authors:  Laura P Edgerley; Yasser Y El-Sayed; Maurice L Druzin; Michaela Kiernan; Kay I Daniels
Journal:  Matern Child Health J       Date:  2007-01-23
View more
  2 in total

1.  Parents' perceptions on COVID-19 vaccination as the new routine for their children ≤ 11 years old.

Authors:  Robin M Humble; Hannah Sell; Sarah Wilson; Manish Sadarangani; Julie A Bettinger; Samantha B Meyer; Ève Dubé; Samuel Lemaire-Paquette; Arnaud Gagneur; Shannon E MacDonald
Journal:  Prev Med       Date:  2022-07-02       Impact factor: 4.637

2.  Differences in stakeholder-reported barriers and implementation strategies between counties with high, middle, and low HPV vaccine initiation rates: a mixed methods study.

Authors:  Stephanie A S Staras; Amanda L Kastrinos; Easton N Wollney; Shivani Desai; La Toya J O'Neal; Versie Johnson-Mallard; Carma L Bylund
Journal:  Implement Sci Commun       Date:  2022-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.